In simple terms, Zosurabalpin is an experimental antibiotic designed to fight against a particularly tough strain of bacteria known as CRAB, which often resists other antibiotics. It operates by preventing a critical component of the bacteria from reaching its surface, effectively weakening the bacteria’s defenses. Currently, Zosurabalpin has shown promising results in mice and is undergoing clinical trials to determine its effectiveness and safety in humans. If successful, this could lead to a new class of antibiotics, offering a significant advancement in the treatment of drug-resistant bacterial infections.
Home » Current Affairs In-depths & Editorials » GS2 » Society & Social Justice » Social Justice » Social Sector » Health » Diseases » Zosurabalpin